India, Feb. 4 -- The Delhi High Court will examine on February 6 the status report filed by the Economic Offences Wing (EOW) in connection with its probe into the alleged Rs.157 crore international counterfeit Ozempic scam, in which the agency said it is investigating the alleged involvement of Dubai-based Indian national Swapnadip Roy, whose name surfaced during the investigation.

EOW's September 2025 status report was filed in the anticipatory bail application preferred by one Vicky Ramancha, accused of criminal conspiracy and cheating a US-based company, Assure Global, by supplying them counterfeit pharmaceutical drugs, specifically Ozempic. Ozempic is used to treat Type-2 Diabetes and is an anti-obesity medication used for long-term ...